Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... "The neurophysiological monitoring market is in a mature stage, but the steady rise of neuropsychiatric disorders and the need to monitor the central and peripheral nervous system of patients ...
2009 NOV 23 ... "The spectrum of these non-motor disturbances is very broad and comprises neuropsychiatric conditions, such as depression, dementia and hallucinations, as well as autonomic, ...
2009 NOV 23 ... refinement and plasticity, whereas abnormal morphogenesis is associated with neuropsychiatric disorders. We found that activation of Epac2, a PKA-independent cAMP target and Rap ...
2009 NOV 23 ... NASDAQ: DDSS) announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue (www.cnsspectrums.com), citing the potential ...
2009 NOV 23 ... inhibitors of monoamine oxidase B (MAO B) are effectively used as therapeutic drugs for neuropsychiatric and neurodegenerative diseases. However, their mechanism of action is not clear, since ...
2009 NOV 24 ... by the Criminal Justice System (Court of Law) at the Department of Forensic Psychiatry, Neuropsychiatric Hospital, Popovaca, Croatia. For the purpose of this work the sample is divided in two ...
2009 NOV 23 ... "Adolescence is characterized by increased vulnerability to developing neuropsychiatric disorders and involves a period of prefrontal cortical dendritic refinement and synaptic ...
2009 NOV 23 ... (PTx). Symptoms ranging from decreased bone mineral density, increased fracture risk, neuropsychiatric symptoms and cognitive changes, lower quality of life, and neuromuscular symptoms were ...
2009 NOV 16 ... variation in gene expression relevant to complex brain related traits, including human neuropsychiatric diseases." Jasinska and colleagues published their study in Human ...
2009 NOV 23 ... in leading sales and marketing initiatives to support the intended launch of RBM's neuropsychiatric diagnostics services. RBM recently announced the identification of a biomarker panel ...
2009 NOV 16 ... and motor impairments.1 The condition encompasses a wide spectrum of often reversible neuropsychiatric abnormalities caused by the inability of the liver to remove toxic products in the gut, ...
2009 NOV 23 ... "Roche has a dedicated effort in improving the lives of patients with neuropsychiatric illness. Patients have impaired cognitive capabilities across many disorders, notably in ...
2009 NOV 16 ... findings implicate abnormal dendritic trafficking of BDNF mRNA in the pathophysiology of neuropsychiatric disorders linked to the G196A mutation." Chiaruttini and colleagues ...
2009 NOV 16 ... of the cohort. The clusters did not differ in behavioural severity as measured by the Neuropsychiatric Inventory; supporting the original classification of the behavioural variant of ...
2009 NOV 16 ... (HPA) axis activity underlie differential vulnerability to neuropsychiatric and metabolic disorders, although the basis of this variation is poorly understood. ...
2009 NOV 23 ... data. The MDD group had completion and SVR rates similar to those of control subjects. Neuropsychiatric side effects and reasons for discontinuation of treatment were not different between ...
2009 NOV 16 ... prevalence study of PD in Rogaland County, Western Norway. Apathy was measured with the Neuropsychiatric Inventory, using a composite score >or=4 to indicate clinically significant apathy. ...
2009 NOV 16 ... Alpha interferons, including PEGINTRON, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely ...
2009 NOV 24 ... and pain, and for understanding how pleasure expectation can go awry in a multitude of neuropsychiatric disorders that implicate dopamine, such as drug addiction," they write. "The current ...
